UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer Journal article
Wang, Yan, Zhang, Chen, Xiao, Meng, Ganesan, Kumar, Gao, Fei, Liu, Qingqing, Ye, Zhen, Sui, Yue, Zhang, Feng, Wei, Kunhua, Wu, Yaobin, Wu, Jianmin, Du, Bing, Xu, Cong, Li, Yan, Li, Peng, Zhang, Jinming, Chen, Jianping. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:  Wang, Yan;  Zhang, Chen;  Xiao, Meng;  Ganesan, Kumar;  Gao, Fei; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:4.5/4.7 | Submit date:2023/02/01
Isoliquiritigenin  Zein-phosphatidylcholine Hybrid Nanoparticles  Bioavailability  Triple-negative Breast Cancer  Safe Therapeutic Strategy  
Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer Journal article
Lin, Xiangping, Wang, Qun, Du, Shuang, Guan, Yucheng, Qiu, Jinmei, Chen, Xiaojia, Yuan, Dongsheng, Chen, Tongkai. Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:  Lin, Xiangping;  Wang, Qun;  Du, Shuang;  Guan, Yucheng;  Qiu, Jinmei; et al.
Favorite | TC[WOS]:21 TC[Scopus]:22  IF:4.5/4.7 | Submit date:2023/02/01
Breast Cancer  Paclitaxel  Curcumin  Co-delivery  Polymeric Nanoparticles  Nf-κb Signaling Pathway  
Dry powder inhalers: A patent review Journal article
Jiawei Wang, Xiangjun Kong, Linfeng Hu, Yuanjia Hu. Dry powder inhalers: A patent review[J]. Journal of Drug Delivery Science and Technology, 2022, 74, 103540.
Authors:  Jiawei Wang;  Xiangjun Kong;  Linfeng Hu;  Yuanjia Hu
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.5/4.7 | Submit date:2022/08/02
Active Ingredients  Dry Powder Inhalers  Indications  Inhibitors  Medicaments  Milestone Patents  
Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers Journal article
Ma, Guanglan, Du, Xiao, Zhu, Jianping, Xu, Feng, Yu, Hua, Li, Juan. Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers[J]. Journal of Drug Delivery Science and Technology, 2021, 63(102493).
Authors:  Ma, Guanglan;  Du, Xiao;  Zhu, Jianping;  Xu, Feng;  Yu, Hua; et al.
Favorite | TC[WOS]:19 TC[Scopus]:23  IF:4.5/4.7 | Submit date:2021/12/08
Liver Cancer  Combination Chemotherapy  Nanomedicine  Micelles  Metastasis